참고문헌
- Bamberger AM, Milde-Langosch K, Rossing E, Goemann C, Loning T (2001): Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 127: 545-550. https://doi.org/10.1007/s004320100255
- Burova EB, Smirnova IS, Gonchar IV, Shatrova AN, Nikolsky NN (2011): Inhibition of the EGF receptor and ERK1/2 signaling pathways rescues the human epidermoid carcinoma A431 cells from IFN gammainduced apoptosis. Cell Cycle 10:2197-2205. https://doi.org/10.4161/cc.10.13.16055
- Campbell A, Wicha MS, Long M (1985): Extracellular matrix promotes the growth and differentiation of murine hematopoietic cells in vitro. J Clin Invest 75: 2085-2090. https://doi.org/10.1172/JCI111928
- De Wilde J, De-Castro Arce J, Snijders PJ, Meijer CJ, Rosl F, Steenbergen RD (2008): Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol 30:77-87.
- Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira- Smith O, et al. (1995): A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA, 92:9363-9367. https://doi.org/10.1073/pnas.92.20.9363
- Flaim CJ, Chien S, Bhatia SN (2005): An extracellular matrix microarray for probing cellular differentiation. Nat Methods 2:119-125. https://doi.org/10.1038/nmeth736
- Glover JN, Harrison SC (1995): Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c- Jun bound to DNA. Nature 373:257-261. https://doi.org/10.1038/373257a0
- Haylock DN, Nilsson SK (2005): Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 4: 1353-1355. https://doi.org/10.4161/cc.4.10.2056
- Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM (2007): Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7:246-255. https://doi.org/10.1038/nrc2108
- Kihara T, Hirose M, Oshima A, Ohgushi H (2006): Exogenous type I collagen facilitates osteogenic differentiation and acts as a substrate for mineralization of rat marrow mesenchymal stem cells in vitro. Biochem Biophys Res Commun 341:1029-1035. https://doi.org/10.1016/j.bbrc.2006.01.059
- Kim MO, Kim SH, Oi N, Lee MH, Yu DH, Kim DJ, Cho EJ, Bode AM, Cho YY, Bowden TG, Dong Z (2011): Embryonic stem-cell-preconditioned microenvironment induces loss of cancer cell properties in human melanoma cells. Pigment Cell Melanoma Res 24:922-931. https://doi.org/10.1111/j.1755-148X.2011.00891.x
- Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ (2006): Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci USA 103:3752-3757. https://doi.org/10.1073/pnas.0506977103
- Kyo S, Klumpp DJ, Inoue M, Kanaya T, Laimins L A (1997): Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol 78 (Pt 2):401-411. https://doi.org/10.1099/0022-1317-78-2-401
- Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ (2005): The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233:1560-1570. https://doi.org/10.1002/dvdy.20471
- Naugle JE, Olson ER, Zhang X, Mase SE, Pilati CF, Maron MB, Folkesson HG, Horne WI, Doane KJ, Meszaros JG (2006): Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol 290:H323-330.
- Neyns B, Teugels E, Bourgain C, Birrerand M, De Greve J (1999): Alteration of jun proto-oncogene status by plasmid transfection affects growth of human ovarian cancer cells. Int J Cancer 82:687-693. https://doi.org/10.1002/(SICI)1097-0215(19990827)82:5<687::AID-IJC11>3.0.CO;2-F
- Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008): Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146. https://doi.org/10.1038/nature06534
- Postovit LM, Seftor EA, Seftor RE, Hendrix MJ (2006): A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells 24:501-505. https://doi.org/10.1634/stemcells.2005-0459
- Prusty BK, Das BC (2005): Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113:951-960. https://doi.org/10.1002/ijc.20668
- Rapp UR, Troppmair J, Beck T, Birrer MJ (1994): Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 9:3493-3498.
- Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M (1998): Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene 16:3057-3068. https://doi.org/10.1038/sj.onc.1201845
- Shaulian E, Karin M (2002): AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136. https://doi.org/10.1038/ncb0502-e131
- Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H (2003): Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 130:2513-2524. https://doi.org/10.1242/dev.00459
- Suzuki T, Murakami M, Onai N, Fukuda E, Hashimoto Y, Sonobe MH, Kameda T, Ichinose M, Miki K, Iba H (1994): Analysis of AP-1 function in cellular transformation pathways. J Virol 68: 3527-3535.
- Vleugel MM, Greijer AE, Bos R, Van Der Wall E, Van Diest PJ (2006): c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum Pathol 37:668-674. https://doi.org/10.1016/j.humpath.2006.01.022
- Wang HL, Wang J, Xiao SY, HaydonR, Stoiber D, He TC, Bissonnette M, Hart J (2002): Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101:301-310. https://doi.org/10.1002/ijc.10630
- Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, Tsukada T, Saga Y, Takeda N, Ikawa Y, Aizawa S (1993): A novel ES cell line, TT2, with high germline- differentiating potency. Anal Biochem 214:70-76. https://doi.org/10.1006/abio.1993.1458